Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Prestige Consumer Healthcare (PBH) over the last 15 years, with Q4 2025 value amounting to $42.8 million.

  • Prestige Consumer Healthcare's Other Operating Expenses rose 430.28% to $42.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $173.3 million, marking a year-over-year increase of 241.41%. This contributed to the annual value of $179.8 million for FY2025, which is 722.38% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Other Operating Expenses of $42.8 million as of Q4 2025, which was up 430.28% from $41.4 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Other Operating Expenses' 5-year high stood at $405.1 million during Q1 2023, with a 5-year trough of $34.8 million in Q4 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's median Other Operating Expenses value was $42.9 million (recorded in 2023), while the average stood at $60.8 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 86186.63% in 2023, then plummeted by 8988.82% in 2024.
  • Prestige Consumer Healthcare's Other Operating Expenses (Quarter) stood at $44.7 million in 2021, then dropped by 22.08% to $34.8 million in 2022, then grew by 23.79% to $43.1 million in 2023, then decreased by 4.87% to $41.0 million in 2024, then increased by 4.3% to $42.8 million in 2025.
  • Its last three reported values are $42.8 million in Q4 2025, $41.4 million for Q3 2025, and $37.6 million during Q2 2025.